Senior Director, Clinical Business Planning
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity
Revolution Medicines is focused on developing targeted therapies for patients with RAS-addicted cancers. The Senior Director, Clinical Business Operations and Strategy will lead the financial and business planning capabilities that support delivery of the global clinical development portfolio.
As a member of Clinical Operations, this leader will oversee study and departmental budgets, forecasting, workforce and resource planning, vendor financial management, and investigator site budgets and payments
